Read + Share
Bewersdorf JP, Stone RM, Tallman MS, Stahl M, et al. Does the conventional cytogenetic risk profile still matter for prediction of
venetoclax based treatment outcomes in AML? Leuk Lymphoma 2021;62:3318-3319.
PMID: 34587866
|
 |
|
Bewersdorf JP, Stone RM, Tallman MS, Stahl M, et al. Does the conventional cytogenetic risk profile still matter for prediction of
venetoclax based treatment outcomes in AML? Leuk Lymphoma 2021;62:3318-3319.
PMID: 34587866
|
|
|
|